| Secondary |
| Hypertension |
32.1% |
| Ischaemic Heart Disease Prophylaxis |
7.4% |
| Renal Failure Chronic |
4.9% |
| Stress Urinary Incontinence |
4.9% |
| Type 2 Diabetes Mellitus |
4.9% |
| Vascular Dementia |
4.9% |
| Cardiac Failure Chronic |
3.7% |
| Extrapyramidal Disorder |
3.7% |
| Initial Insomnia |
3.7% |
| Osteoporosis |
3.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.7% |
| Anaemia Of Chronic Disease |
2.5% |
| Angina Pectoris |
2.5% |
| Atrial Fibrillation |
2.5% |
| Gastric Ulcer |
2.5% |
| Hyperlipidaemia |
2.5% |
| Iron Deficiency |
2.5% |
| Oedema |
2.5% |
| Restless Legs Syndrome |
2.5% |
| Thrombosis Prophylaxis |
2.5% |
|
| Renal Failure Acute |
33.3% |
| Fallot's Tetralogy |
20.0% |
| Ventricular Fibrillation |
13.3% |
| Vertigo |
13.3% |
| Cardiac Failure |
6.7% |
| Hyponatraemia |
6.7% |
| Vomiting |
6.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
50.1% |
| Drug Use For Unknown Indication |
17.0% |
| Hypertension |
4.2% |
| Cardiac Failure |
3.6% |
| Rheumatoid Arthritis |
2.5% |
| Type 2 Diabetes Mellitus |
2.2% |
| Atrial Fibrillation |
2.0% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Coronary Artery Disease |
1.9% |
| Parkinson's Disease |
1.9% |
| Metastatic Malignant Melanoma |
1.5% |
| Non-small Cell Lung Cancer |
1.5% |
| Diabetes Mellitus |
1.4% |
| Osteoporosis |
1.4% |
| Pain |
1.4% |
| Ascites |
1.2% |
| Breast Cancer |
1.2% |
| Depression |
1.2% |
| Benign Prostatic Hyperplasia |
1.0% |
| Renal Transplant |
1.0% |
|
| Death |
10.0% |
| General Physical Health Deterioration |
10.0% |
| Hallucination |
7.1% |
| Pericardial Haemorrhage |
7.1% |
| Sepsis |
7.1% |
| Pleural Effusion |
5.7% |
| Rhabdomyolysis |
5.7% |
| Acute Myocardial Infarction |
4.3% |
| Haemoglobin Decreased |
4.3% |
| Hepatitis |
4.3% |
| Off Label Use |
4.3% |
| Prostate Cancer |
4.3% |
| Pulmonary Embolism |
4.3% |
| Urinary Tract Infection |
4.3% |
| Blood Creatinine Increased |
2.9% |
| Bradycardia |
2.9% |
| Bursitis |
2.9% |
| Coronary Artery Disease |
2.9% |
| Dialysis |
2.9% |
| Gastrointestinal Haemorrhage |
2.9% |
|
| Interacting |
| Hypertension |
26.9% |
| Ischaemic Heart Disease Prophylaxis |
15.4% |
| Product Used For Unknown Indication |
11.5% |
| Extrapyramidal Disorder |
7.7% |
| Initial Insomnia |
7.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
7.7% |
| Stress Urinary Incontinence |
7.7% |
| Vascular Dementia |
7.7% |
| Pruritus |
3.8% |
| Urinary Tract Infection |
3.8% |
|
| Renal Failure Acute |
100.0% |
|
